1. A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women. (September 2020) Authors: Tsai, Meng-shan; Chang, Shu-Han; Kuo, Wen-Hung; Kuo, Ching-Hua; Li, Szu-Yi; Wang, Ming-Yang; Chang, Dwan-Ying; Lu, Yen-Shen; Huang, Chiun-Sheng; Cheng, Ann-Lii; Lin, Ching-Hung; Chen, Pau-Chung Journal: Environment international Issue: Volume 142(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer. (5th January 2018) Authors: Chen, Tom Wei-Wu; Yeh, Dah-Cherng; Chao, Tsu-Yi; Lin, Ching-Hung; Chow, Louis Wing-Cheong; Chang, Dwan-Ying; Hsieh, Yao-Yu; Huang, Shu-Min; Cheng, Ann-Lii; Lu, Yen-Shen; Consortium, Taiwan Breast Cancer Journal: Japanese journal of clinical oncology Issue: Volume 48:Number 3(2018) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients. (October 2021) Authors: Chen, I-Chun; Hu, Fu-Chang; Lin, Ching-Hung; Huang, Shu-Min; Chang, Dwan-Ying; Cheng, Ann-Lii; Lu, Yen-Shen Journal: Breast Issue: Volume 59(2021) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation. Issue 2 (25th December 2012) Authors: Lin, Ching-Hung; Liu, Jacqueline M; Lu, Yen-Shen; Lan, Chieh; Lee, Wei-Chung; Kuo, Kuan-Ting; Wang, Chung-Chieh; Chang, Dwan-Ying; Huang, Chiun-Sheng; Cheng, Ann-Lii Journal: Journal of clinical pathology Issue: Volume 66:Issue 2(2013) Page Start: 140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?. Issue 9 (4th June 2011) Authors: Lin, Ching-Hung; Lu, Yen-Shen; Huang, Chiun-Sheng; Kuo, Kuan-Ting; Wang, Chung-Chieh; You, San-Lin; Lin, Po-Han; Chang, Dwan-Ying; Kuo, Wen-Hung; Chang, King-Jen; Cheng, Ann-Lii Journal: Journal of clinical pathology Issue: Volume 64:Issue 9(2011) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗